Compare IPCA Labs with TTK HEALTHCARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs TTK HEALTHCARE - Comparison Results

IPCA LABS     Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    IPCA LABS TTK HEALTHCARE IPCA LABS/
TTK HEALTHCARE
 
P/E (TTM) x 24.1 12.4 194.3% View Chart
P/BV x 8.6 1.8 478.6% View Chart
Dividend Yield % 0.1 0.9 16.4%  

Financials

 IPCA LABS   TTK HEALTHCARE
EQUITY SHARE DATA
    IPCA LABS
Mar-19
TTK HEALTHCARE
Mar-19
IPCA LABS/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs1,0421,215 85.8%   
Low Rs590610 96.7%   
Sales per share (Unadj.) Rs298.6444.4 67.2%  
Earnings per share (Unadj.) Rs35.017.2 202.9%  
Cash flow per share (Unadj.) Rs49.427.6 178.9%  
Dividends per share (Unadj.) Rs3.005.00 60.0%  
Dividend yield (eoy) %0.40.5 67.1%  
Book value per share (Unadj.) Rs247.1177.9 138.9%  
Shares outstanding (eoy) m126.3514.13 894.2%   
Bonus/Rights/Conversions ESOS--  
Price / Sales ratio x2.72.1 133.1%   
Avg P/E ratio x23.352.9 44.1%  
P/CF ratio (eoy) x16.533.0 50.0%  
Price / Book Value ratio x3.35.1 64.4%  
Dividend payout %8.629.0 29.6%   
Avg Mkt Cap Rs m103,10812,894 799.6%   
No. of employees `00013.42.3 581.4%   
Total wages/salary Rs m7,8741,307 602.4%   
Avg. sales/employee Rs Th2,807.02,715.7 103.4%   
Avg. wages/employee Rs Th585.8565.3 103.6%   
Avg. net profit/employee Rs Th329.0105.4 312.1%   
INCOME DATA
Net Sales Rs m37,7326,279 600.9%  
Other income Rs m57778 744.3%   
Total revenues Rs m38,3096,356 602.7%   
Gross profit Rs m6,901496 1,392.4%  
Depreciation Rs m1,824147 1,243.5%   
Interest Rs m18934 558.3%   
Profit before tax Rs m5,465393 1,391.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,042149 700.1%   
Profit after tax Rs m4,422244 1,814.6%  
Gross profit margin %18.37.9 231.7%  
Effective tax rate %19.137.9 50.3%   
Net profit margin %11.73.9 302.0%  
BALANCE SHEET DATA
Current assets Rs m23,7782,717 875.1%   
Current liabilities Rs m10,9751,571 698.7%   
Net working cap to sales %33.918.3 185.8%  
Current ratio x2.21.7 125.2%  
Inventory Days Days10432 322.7%  
Debtors Days Days6647 141.3%  
Net fixed assets Rs m20,368991 2,055.3%   
Share capital Rs m253141 178.8%   
"Free" reserves Rs m30,9712,373 1,305.2%   
Net worth Rs m31,2242,514 1,241.9%   
Long term debt Rs m1,4093 41,426.5%   
Total assets Rs m45,5074,158 1,094.4%  
Interest coverage x30.012.6 237.5%   
Debt to equity ratio x00 3,335.9%  
Sales to assets ratio x0.81.5 54.9%   
Return on assets %10.16.7 151.8%  
Return on equity %14.29.7 146.1%  
Return on capital %17.316.9 102.3%  
Exports to sales %45.93.6 1,279.0%   
Imports to sales %16.60.5 3,369.2%   
Exports (fob) Rs m17,308225 7,685.8%   
Imports (cif) Rs m6,26631 20,246.8%   
Fx inflow Rs m17,308225 7,685.8%   
Fx outflow Rs m6,26671 8,812.3%   
Net fx Rs m11,042154 7,165.9%   
CASH FLOW
From Operations Rs m4,923173 2,843.9%  
From Investments Rs m-1,56397 -1,619.8%  
From Financial Activity Rs m-1,832-307 596.2%  
Net Cashflow Rs m1,528-38 -4,052.3%  

Share Holding

Indian Promoters % 45.9 65.4 70.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 11.4 3.7 308.1%  
FIIs % 25.3 5.2 486.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.4 25.8 67.4%  
Shareholders   36,892 12,723 290.0%  
Pledged promoter(s) holding % 2.1 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare IPCA LABS With:   J.B.CHEMICALS  SUVEN LIFE SCIENCES  WYETH  ELDER PHARMA  VENUS REMEDIES  

Compare IPCA LABS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Falls 471 Points, Nifty Ends Below 14,700; Tata Steel & JSW Steel Top Losers(Closing)

Indian share markets witnessed selling pressure throughout the day today and ended lower.

Related Views on News

IPCA LABS Announces Quarterly Results (3QFY21); Net Profit Up 32.2% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, IPCA LABS has posted a net profit of Rs 3 bn (up 32.2% YoY). Sales on the other hand came in at Rs 13 bn (up 15.5% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (3QFY21); Net Profit Up 71.7% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, TTK HEALTHCARE has posted a net profit of Rs 77 m (up 71.7% YoY). Sales on the other hand came in at Rs 2 bn (up 8.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

IPCA LABS Announces Quarterly Results (1QFY21); Net Profit Up 243.5% (Quarterly Result Update)

Sep 29, 2020 | Updated on Sep 29, 2020

For the quarter ended June 2020, IPCA LABS has posted a net profit of Rs 5 bn (up 243.5% YoY). Sales on the other hand came in at Rs 15 bn (up 46.9% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (3QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, IPCA LABS has posted a net profit of Rs 2 bn (up 22.8% YoY). Sales on the other hand came in at Rs 11 bn (up 20.2% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (3QFY20); Net Profit Down 8.3% (Quarterly Result Update)

Jan 30, 2020 | Updated on Jan 30, 2020

For the quarter ended December 2019, TTK HEALTHCARE has posted a net profit of Rs 45 m (down 8.3% YoY). Sales on the other hand came in at Rs 2 bn (up 11.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

More Views on News

Most Popular

The Next Smallcap Winners(Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Time to Buy Smallcaps?(Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

Are the Stock Markets Deaf to Covid Agony?(Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

My Secret to Find Breakthrough Stocks(Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

IPCA LABS SHARE PRICE


May 12, 2021 (Close)

TRACK IPCA LABS

  • Track your investment in IPCA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

IPCA LABS - SANOFI INDIA COMPARISON

COMPARE IPCA LABS WITH

MARKET STATS